Registered Trials

• NCT04805125

  Phase 3

  Switzerland

  Total Enrollment: 380

  Official Trial Registration:

  • NCT04805125(Opens in new tab/window)

• NCT04800133

  Phase 3

  Hong Kong

  Total Enrollment: 900

  Official Trial Registration:

  • NCT04800133(Opens in new tab/window)

• NCT04951323

  Phase 3

  Belgium

  Total Enrollment: 50

  Official Trial Registration:

  • NCT04951323(Opens in new tab/window)

• NCT04713553

  Phase 3

  United States of America

  Total Enrollment: 1,530

  Official Trial Registration:

  • NCT04713553(Opens in new tab/window)

• NCT04816669

  Phase 3

  United States of America

  Total Enrollment: 550

  Official Trial Registration:

  • NCT04816669(Opens in new tab/window)

• NCT04368728, EUCTR2020-002641-42

  Phase 2/3

  Argentina, Brazil, Germany, South Africa, Turkey, United States of America

  Total Enrollment: 43,998

  Official Trial Registration:

  • NCT04368728(Opens in new tab/window)
  • EUCTR2020-002641-42(Opens in new tab/window)

• NCT05022329

  Phase 2/3

  Canada

  Total Enrollment: 300

  Official Trial Registration:

  • NCT05022329(Opens in new tab/window)

• NCT04754594

  Phase 2/3

  United States of America

  Total Enrollment: 4,000

  Official Trial Registration:

  • NCT04754594(Opens in new tab/window)

• NCT04949490

  Phase 2

  Total Enrollment: 549

  Official Trial Registration:

  • NCT04949490(Opens in new tab/window)

• NCT04969263

  Phase 2

  United States of America

  Total Enrollment: 200

  Official Trial Registration:

  • NCT04969263(Opens in new tab/window)

• NCT04761822

  Phase 2

  United States of America

  Total Enrollment: 3,400

  Official Trial Registration:

  • NCT04761822(Opens in new tab/window)

• NCT04992182

  Phase 2

  Chile

  Total Enrollment: 534

  Official Trial Registration:

  • NCT04992182(Opens in new tab/window)

• ISRCTN69254139

  Phase 2

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 820

  Official Trial Registration:

  • ISRCTN69254139(Opens in new tab/window)

• NCT04860739, EUCTR2021-001978-37

  Phase 2

  Spain

  Total Enrollment: 676

  Official Trial Registration:

  • NCT04860739(Opens in new tab/window)
  • EUCTR2021-001978-37(Opens in new tab/window)

• NCT04907331

  Phase 2

  Austria

  Total Enrollment: 3,000

  Official Trial Registration:

  • NCT04907331(Opens in new tab/window)

• NCT04649021

  Phase 2

  China

  Total Enrollment: 950

  Official Trial Registration:

  • NCT04649021(Opens in new tab/window)

• NCT04824638

  Phase 2

  France

  Total Enrollment: 300

  Official Trial Registration:

  • NCT04824638(Opens in new tab/window)

• NCT04895982

  Phase 2

  Brazil, Germany, United States of America

  Total Enrollment: 360

  Official Trial Registration:

  • NCT04895982(Opens in new tab/window)

• EUCTR2020-005442-42

  Phase 1/2/3

  Finland, Poland, Spain, United States of America

  Total Enrollment: 4,644

  Official Trial Registration:

  • EUCTR2020-005442-42(Opens in new tab/window)

• EUCTR2020-001038-36, NCT04380701

  Phase 1/2

  Germany

  Total Enrollment: 456

  Official Trial Registration:

  • EUCTR2020-001038-36(Opens in new tab/window)
  • NCT04380701(Opens in new tab/window)

• NCT04969601

  Phase 1/2

  France

  Total Enrollment: 150

  Official Trial Registration:

  • NCT04969601(Opens in new tab/window)

• NCT04588480

  Phase 1/2

  Japan

  Total Enrollment: 160

  Official Trial Registration:

  • NCT04588480(Opens in new tab/window)

• NCT04839315

  Phase 1

  United States of America

  Total Enrollment: 100

  Official Trial Registration:

  • NCT04839315(Opens in new tab/window)

• NCT04936997

  Phase 1

  United States of America

  Total Enrollment: 1,000

  Official Trial Registration:

  • NCT04936997(Opens in new tab/window)

• NCT04816643

  Phase 1

  United States of America

  Total Enrollment: 4,644

  Official Trial Registration:

  • NCT04816643(Opens in new tab/window)